The retinoic acid receptor-alpha [74] could be another considered candidate for the treatment of autoimmunity, because signaling through a specific nuclear retinoic acid receptor can favor the decision to adopt the Treg cell fate at the expense of the Th17 cell fate. This evidence concerns the gene RARA and Autoimmunity.